Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (121-130 of 255) with videos related to

Pageof 26
Sort By:
Clinical Chemistry|September 22, 2012
Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapySukhbinder Dhesy-Thind, Vikaash Kumar, Aidan Snider-McNair, et al.
European Urology Oncology|August 15, 2019
Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 TrialsGuru P Sonpavde, Gregory R Pond, Karim Fizazi, et al.
Clinical Genitourinary Cancer|June 22, 2016
Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-AnalysisAndrea Necchi, Gregory R Pond, Daniele Raggi, et al.
The Journal of Urology|August 21, 2015
Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial CarcinomaGuru Sonpavde, Gregory R Pond, Jonathan E Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Analysis of treatment practices for elderly cancer patients in Ontario, CanadaCarol Townsley, Gregory R Pond, Brenda Peloza, et al.
Blood Cancer Journal|November 22, 2025
Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based studyBrittany Salter, Alejandro Garcia-Horton, Irwin Walker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agentsGregory R Pond, Lillian L Siu, Malcolm Moore, et al.
Journal of Geriatric Oncology|July 21, 2023
Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysisJoanne Britto, Hsien Seow, Gregory R Pond, et al.
Plos One|January 4, 2017
Claudin-Low Breast Cancer; Clinical & Pathological CharacteristicsKay Dias, Anna Dvorkin-Gheva, Robin M Hallett, et al.
Radiology|July 16, 2024
Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate CancerSangeet Ghai, Laurence Klotz, Gregory R Pond, et al.
Pageof 26

Showing results (121-130 of 255) with videos related to

Sort By:
Pageof 26
Clinical Chemistry|September 22, 2012
Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapySukhbinder Dhesy-Thind, Vikaash Kumar, Aidan Snider-McNair, et al.
European Urology Oncology|August 15, 2019
Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 TrialsGuru P Sonpavde, Gregory R Pond, Karim Fizazi, et al.
Clinical Genitourinary Cancer|June 22, 2016
Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-AnalysisAndrea Necchi, Gregory R Pond, Daniele Raggi, et al.
The Journal of Urology|August 21, 2015
Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial CarcinomaGuru Sonpavde, Gregory R Pond, Jonathan E Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Analysis of treatment practices for elderly cancer patients in Ontario, CanadaCarol Townsley, Gregory R Pond, Brenda Peloza, et al.
Blood Cancer Journal|November 22, 2025
Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based studyBrittany Salter, Alejandro Garcia-Horton, Irwin Walker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agentsGregory R Pond, Lillian L Siu, Malcolm Moore, et al.
Journal of Geriatric Oncology|July 21, 2023
Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysisJoanne Britto, Hsien Seow, Gregory R Pond, et al.
Plos One|January 4, 2017
Claudin-Low Breast Cancer; Clinical & Pathological CharacteristicsKay Dias, Anna Dvorkin-Gheva, Robin M Hallett, et al.
Radiology|July 16, 2024
Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate CancerSangeet Ghai, Laurence Klotz, Gregory R Pond, et al.
Pageof 26